Advertise on podcast: SkinSync

Type II immunity has become a well known crucial part of the inflammatory cascade in dermatologic disease. Skin Sync host and PA Eileen Cheever sat down with Dr. James Song to discuss why it matters in pathophysiology and therapeutic decisions.

Special conference coverage from the Elevate-Derm summer conference in San Diego, featuring Dr. James Song. Listen to review what you learned or see what you missed from our favorite immunology expert!

Special conference coverage from the Elevate-Derm summer conference in San Diego, featuring Dr. Daniel Butler and Dr. Julia Cremer. Listen to review what you learned or see what you missed and don't miss this dynamic husband-wife duo talking geriatric medicine!

Special conference coverage from the Elevate-Derm summer conference in San Diego, featuring Dr. April Armstrong, Dr. Walter Liszewski, Dr. Maria Robinson, and Dr. Ashley Elsensohn. Listen to see what you missed or review what you learned!

Special conference coverage from the Elevate-Derm summer conference in San Diego, featuring Dr.. Oyetewa Asempa and Dr. Jashin Wu. Listen to see what you missed or review what you learned!

Itch can be debilitating for atopic dermatitis patients. For years, we were stuck in cycles of topical corticosteroid use to provide temporary relief. Modern targeted topical therapies, however, offer safe, efficacious clearance of atopic dermatitis and rapid itch relief for adult and pediatric patients. Tune in to hear the data on itch relief for our advanced, targeted topical therapies.

Not sure how to approach starting a patient on a JAK inhibitor in your clinic? In this episode we discuss the benefits and risks of JAK inhibitors in dermatology and how to make informed, confident, shared decisions with your patients.

Atopic dermatitis is often associated with a host of atopic diseases, like allergies, asthma, and food allergy. We discussed all things atopic with an allergy expert, Dr. Payel Gupta. Tune in to hear her expert advice on how we can prevent the progression of the atopic march by treating the skin early!

Psoriatic arthritis is estimated to affect more than a third of patients with plaque psoriasis. Early recognition and treatment is critical in preventing permanent joint destruction. We sat down with psoriasis expert and Chief of Dermatology at UCLA, Dr. April Armstrong, to discuss how she screens for psoriatic arthritis and treats with confidence in her clinic.

Did you know that tapinarof was discovered on a nematode and has a unique agonist mechanism of action with anti-inflammatory and skin barrier benefit in both psoriasis and atopic dermatitis? Listen in as Skin Sync hosts, Buchi Neita and Shanna Miranti, take us through the science and clinical trial data.

Pediatric patients with atopic dermatitis often face disruptions in sleep, growth and development, and behavioral challenges that can greatly impact their quality of life. The advancement of systemic biologic therapy in children with atopic dermatitis is shown to improve outcomes across the board for these patients. Listen in as we discuss this revolutionary data in detail with Dr. Lisa Swanson, dermatologist extrodinairre, and host of her own podcast, Skincredible.

How do you approach shared decision making with your patients? Tune in to hear how our podcasts hosts ensure patients have ownership in their own dermatological care and are comfortable with the treatment path they discuss.

Rounding out our hair loss mini series, this episode focuses on scarring alopecia-from diagnosis, to treatment, to patient counseling strategies.

Continuing the hair loss mini series, PAs Buchi Neita and Lisa Weiss look at non-scarring alopecias in detail, discuss their approach to management, and one of our hosts shares her own personal journey with hair loss.

In honor of national hair loss awareness month, podcast hosts Buchi Neita and Lisa Weiss take a deep dive into hair loss. In this episode they discuss the initial visit, history, physical exam, and importance of the psychosocial impact of hair loss on our patients.